Skip to main content

Table 5 Clinical details of 12 patients with metastatic infections associated with K. pneumoniae liver abscess

From: Clinical features and development of Sepsis in Klebsiella pneumoniae infected liver abscess patients: a retrospective analysis of 135 cases

Patient

Age, years

Sex

infection site

Underlying disease(s)

Severe complication(s)

Location of abscess

WBC

(X109/L)

Neutrophil

(%)

CRP

(mg/L)

PCT

(ng/ml)

Antibiotics history

Outcome

1

60

F

lung

HTN, chronic renal insufficiency

MODF,ARDS,AKI Septic shock,

Left side

12.7

88

136

76

IMP+LEV

Died

2

55

M

Lung peritoneum

DM

Septic shock

Right side

12.6

92

316

157.7

MEM + MXF

Survived

3

58

M

Lung eye

None

None

Right side

14.2

81

74.1

0.49

CRO+ LEV

Survived

4

46

M

Lung eye

HTN, DM, liver cirrhosis

Septic shock

Right side

10

87.7

137.8

7.77

IMP, TZP

Survived

5

82

F

Lung pleura

HTN, Cholelithiasis,Cardiovascular diseases

None

Right side, multiple

15.6

88

104

1.55

MXF + MEM

Survived

6

50

F

lung

chronic hepatitis

MODF,ARDS, Septic shock, DIC

Right side

21.5

96.3

176.7

100

CAZ, MEM + LEV

Survived

7

32

M

Lung

HTN, DM,

Septic shock, ARDS

Right side

11.4

89.6

238.6

8.49

IMP, CAZ

Survived

8

83

F

Lung

Cardiovascular diseases

Septic shock

Right side, multiple

10.6

93.3

311.18

73

CRO, SCF

Survived

9

61

M

Lung CNS eye

HTN, DM, Cardiovascular diseases

ARDS

Right side, multiple

23.4

95.5

113.1

24.2

CRO,TZP, MEM

Died

10

48

M

Lung eye

HTN, DM

None

Right side

33.3

89.5

132.5

20.32

TZP+ LEV

Survived

11

53

F

Lung pleura

HTN, DM, anemia

AKI

Right side

9.3

94.2

267.9

23.25

TZP, IMP, CAZ

Survived

12

53

F

pleura

DM, anemia

None

Left side

10.4

82.5

130.8

25.8

TZP

Survived

  1. HTN hypertension, MODF multiple organ dysfunction syndrome, ARDS acute respiratory distress syndrome, DIC disseminated intravascular coagulation, AKI acute kidney injury, TZP Piperacillin/tazobactam, LEV Levofloxacin, IMP Imipenem, MEM Meropenem, CAZ Ceftazidime, CRO cefatriaxone, MXF Moxifloxacin, SCF Cefperazone/sulbactam